Melperon

Melperone Hydrochloride, the active ingredient in Melperon, is a typical antipsychotic presented as an oral dosage form for oral use. It is employed in the management of schizophrenia and other psychotic disorders in adult patients. GNH USA supplies Melperon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melperon is a typical antipsychotic that acts on dopaminergic pathways to control psychotic symptoms. - Schizophrenia: reduces hallucinations, delusions and thought disorder. - Acute psychotic episodes: stabilises mood and diminishes severe agitation. - Chronic psychotic disorders: helps maintain long‑term symptom control.

Melperon may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Sedation: feeling unusually drowsy or sleepy. - Extrapyramidal symptoms: muscle stiffness, tremor or restlessness. - Weight gain: increase in body weight over time. - Dry mouth: reduced salivation leading to discomfort. - Constipation: slowed bowel movements. - Orthostatic hypotension: dizziness upon standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening fever and muscle rigidity. - Tardive dyskinesia: persistent involuntary facial movements. - Agranulocytosis: severe reduction in white blood cells. - Seizures: risk of convulsive episodes. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmia: irregular heart rhythm.

When prescribing Melperon, clinicians should consider several safety measures. - Monitor extrapyramidal symptoms: assess for rigidity, tremor or abnormal movements. - Assess cardiovascular status: watch for hypotension and arrhythmias. - Use caution in elderly patients: increased sensitivity to sedation and falls. - Avoid abrupt discontinuation: taper dose to reduce withdrawal effects. - Evaluate hepatic and renal function: adjust use if organ impairment is present. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Melperon can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, opioids): may cause excessive sedation or respiratory depression. - Antihypertensives: additive hypotensive effect. - Drugs that prolong QT interval: increased risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen dry mouth and constipation. - CYP2D6 inhibitors (e.g., fluoxetine): can raise melperon plasma levels. - Antipsychotic polytherapy: heightened risk of extrapyramidal symptoms and metabolic effects.